rel-((6R,8aR)-Hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol

Catalog No. :
ACEDRZ795
CAS No. :
2820537-05-9
Molecular Formula :
C8H15NO2
Molecular Weight :
157.21

IUPAC Name:((6S,8aS)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol

rel-((6R,8aR)-Hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$602.00Login to see priceInquiryInquiry
500mg98%$2135.00Login to see priceInquiryInquiry
1g98%$3186.00Login to see priceInquiryInquiry
5g98%$9558.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-((6R,8aR)-Hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol
IUPAC Name((6S,8aS)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol
Molecular FormulaC8H15NO2
Molecular Weight157.21
SMILESOC[C@@H]1CC[C@@]2([H])COCCN21
InChI KeyPLKGALKKFCRDSA-YUMQZZPRSA-N
Synonym1H-Pyrrolo[2,1-c][1,4]oxazine-6-methanol, hexahydro-, (6R,8aR)-rel-;rel-((6S,8aS)-Hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol;cis-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl]methanol;rel-((6R,8aR)-Hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-6-yl)methanol
CAS No.2820537-05-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACEDRZ795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEDRZ795 route product structure diagram
    ACEDRZ7952820537-05-9
Inquiry

2. ACEDRZ795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEDRZ795 route product structure diagram
    ACEDRZ7952820537-05-9
Inquiry

Comments (0)